C4 Therapeutics Inc (CCCC)

Stock price, financials, and technical signals for C4 Therapeutics Inc (CCCC).

$3.30

0.03

(0.92%)

As of 02/12/2025 5:00 PM ETDisclaimer
Powered by Stocksift.com

100%

CCCC Performance Snapshot


1-Week Chg

-9.59%

1-Month Chg

-9.96%

3-Month Chg

-40.11%

6-Month Chg

-42.31%

1-Year Chg

-51.18%

Year-To-Date Chg

-9.84%

Beta 1-Year

2.35

Beta 5-Year

2.89

Volatility (10-Day)

3.98%

CCCC Technicals



Datesorted descending
Close
Change 1D
Open
High
Low
Typical
Volume

2025-02-12

$3.30

$0.03 (0.92%)

$3.21

$3.32

$3.16

$3.26

554.97K ($1.83M)

2025-02-11

$3.27

-$0.10 (-2.97%)

$3.34

$3.34

$3.20

$3.27

1.57M ($5.12M)

2025-02-10

$3.37

-$0.18 (-5.07%)

$3.58

$3.59

$3.31

$3.42

1.47M ($4.95M)

2025-02-07

$3.55

-$0.03 (-0.84%)

$3.59

$3.69

$3.50

$3.58

1.46M ($5.19M)

2025-02-06

$3.58

-$0.07 (-1.92%)

$3.67

$3.72

$3.57

$3.62

1.39M ($4.99M)

2025-02-05

$3.65

$0.25 (7.35%)

$3.41

$3.71

$3.41

$3.59

1.59M ($5.81M)

2025-02-04

$3.40

$0.04 (1.19%)

$3.35

$3.45

$3.31

$3.39

1.17M ($3.98M)

2025-02-03

$3.36

-$0.11 (-3.17%)

$3.38

$3.46

$3.25

$3.36

2.66M ($8.94M)

2025-01-31

$3.47

-$0.21 (-5.71%)

$3.71

$3.84

$3.40

$3.57

3.24M ($11.24M)

2025-01-30

$3.68

$0.09 (2.51%)

$3.64

$3.78

$3.58

$3.68

1.55M ($5.71M)

CCCC Financials


Balance Sheet

(USD)

2024 Q3

Y/Y CHANGE


  • Cash and equivalents

    $63.09M

    -2.07%

  • Total assets

    $376.06M

    12.93%

  • Total liabilities

    $133.40M

    14.03%

  • Total investments

    $224.75M

    21.19%

  • Shareholders' equity

    $242.66M

    12.33%

  • Book value per share

    $3.48

    -20.62%


Income Statement

(USD)

2024 Q3

Y/Y CHANGE


  • Revenue

    $15.36M

    38.75%

  • Net income

    -$24.67M

    8.77%

  • Operating expense

    $43.61M

    12.16%

  • Gross profit

    $15.36M

    38.75%

  • EBITDA

    -$22.61M

    5.29%

  • Earnings per share

    -$0.35

    36.36%


Cash Flow

(USD)

2024 Q3

Y/Y CHANGE


  • Net change in cash

    -$13.46M

    -182.79%

  • Cash from operations

    -$24.13M

    21.41%

  • Cash from investing

    $162.00K

    -99.72%

  • Cash from financing

    $10.51M

    197.70%

  • Free cash flow

    -$24.12M

    22.96%

  • Free cash flow per share

    -$0.35

    45.60%


Metrics

(USD)

2024 Q3

Y/Y CHANGE


  • Market capitalization

    $395.23M

    331.96%

  • Enterprise value

    $387.09M

    204.69%

  • Shares outstanding

    69.34M

    40.96%

  • Profit margin

    -160.60%

    34.23%

  • Gross margin

    100.00%

    0%

  • EBITDA margin

    -147.20%

    31.73%


Dividends

(USD)

2024 Q3

Y/Y CHANGE


  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    0%

    0%

  • Coverage ratio

    -

    -

  • Current ratio

    6.31

    -14.59%


Stocksift logo icon

Stocksift Uses Cookies

We use cookies to improve and customize your experience on our site. By using our site, you agree to our use of cookies.